La keratose actinique au diapason de la photocarcinogenese en champs. Un concept revisite.

Administration, Topical; Antineoplastic Agents/therapeutic use; Humans; Keratosis, Actinic/etiology/therapy; Sunlight/adverse effects; Ultraviolet Rays/adverse effects

Abstract :

[en] Actinic keratosis should no more be considered as a single neoplasm calling for an individual treatment. The concept of actinic photocarcinogenesis presently turns upside down the perception of skin cancers induced by nonionizing electromagnetic radiations. Currently, the clinician should cope with the whole skin area that has been damaged by chronic exposures to the visible and the invisible spectrum of the light. The therapeutic archetypes are 5-fluorouracile 5% and imiquimod 5% carefully applied to the skin area.

Disciplines :

Dermatology

Author, co-author :

QUATRESOOZ, Pascale ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

PAQUET, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Dermatologie

PIERARD, Gérald ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Language :

French

Title :

La keratose actinique au diapason de la photocarcinogenese en champs. Un concept revisite.

Alternative titles :

[en] Actinic keratosis in tune with field photocarcinogenesis. A revisited concept

Publication date :

2010

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

Pages :

619-22

Peer reviewed :

Peer reviewed

Available on ORBi :

since 27 December 2011

Statistics

Number of views

102 (0 by ULiège)

Number of downloads

4 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Piérard GE, Basset-Seguin N, Hengge U, et al. - Actinic keratosis under scrutiny - 20 questions and answers. Publ. Meda Pharma, Bruxelles 2009, 1-62.
Larsson P, Andersson E, Johansson U, et al. - Ultraviolet A and B affect human melanocytes and keratinocytes differently. A study of oxidative alterations and apoptosis. Exp Dermatol, 2005, 14, 117-123. (Pubitemid 40277578)
Brozyna A, Zbytek B, Granese J, et al. - Mechanism of UV-related carcinogenesis and its contribution to nevi/ melanoma. Expert Rev Dermatol, 2007, 2, 451-469.
Petit L, Fogouang L, Uhoda I, et al. - Regional variability in mottled photo-induced melanoderma in the elderly. Exp Gerontol, 2003, 38, 327-331.
Quatresooz P, Petit L, Uhoda I, et al. - Mosaic sub-clinical melanoderma. An Achilles heel for UV-related epidermal carcinogenesis ? Int J Oncol, 2004, 25, 1763-1767.
Quatresooz P, Piérard-Franchimont C, Henry F, et al. - Mélanodermie infraclinique et cancers photo-induits. Dans : Actualités en Ingénierie Cutanée. Uhoda E, Paye M, Piérard GE (eds). Publ. Eska, Paris, 2006, 4, 67-73.
Slaughter DP, Southwick WH, Smejkal W. - «Field cancerization » in oral stratified squamous epithelium : clinical implications of multicentric origin. Cancer, 1953, 6, 963-968.
Stern RS, Bolshakov S, Nataraj AJ, et al. - p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet A-treated patients : evidence for heterogeneity and field cancerisation. J Invest Dermatol, 2002, 119, 522-526. (Pubitemid 35001966)
Braakhuis BJ, Tabor MP, Kummer JA, et al. - A genetic explanation of Slaughter's concept of field cancerisation: evidence and clinical implications. Cancer Res, 2003, 63, 1727-1730.
Dakubo GE, Jakupciak JP, Birch-Machin MA, Parr RL. - Clinical implications and utility of field cancerisation. Cancer Cell Int, 2007, 7, 2.
Uhoda I, Quatresooz P, Piérard-Franchimont C, Piérard GE. - Nudging epidermal field cancerogenesis by imiquimod. Dermatology, 2003, 206, 357-360.
Vatve M, Ortonne JP, Birch-Marchin MA, Gupta G. - Management of field change in actinic keratosis. Br J Dermatol, 2007, 157, S21-S24.
Quatresooz P, Xhauflaire-Uhoda E, Piérard-Franchimont C, Piérard GE. - Epidermal field carcinogenesis in the bald-headed. An attempt at fine-tuning early non invasive detection. Oncol Report, 2009, 21, 1313-1316.
Xhauflaire-Uhoda E, Piérard-Franchimont C, Piérard GE, Quatresooz P. - Weathering of the hairless scalp: a study using skin capacitance imaging and ultraviolet light -enhanced visualization. Clin Exp Dermatol, 2010, 35, 83-85.
Szepetiuk G, Quatresooz P, Piérard-Franchimont C, Piérard GE.- Indaguer la cancérogenèse, la carcinogenèse et la photocarcinogenèse en champs : de l'invisible au patient. Dermatol Actual, 2009, 116, 14-19.
Piérard GE. - Voir les cancers cutanés en 3D et survivre. Rev Med Liège, 2009, 64, 187-191.
Quatresooz P, Piérard-Franchimont C, Paquet P, et al. - Crossroads between actinic keratosis and squamous cell carcinoma, and novel pharmacological issues. Eur J Dermatol, 2008, 18, 6-10. (Pubitemid 351158165)
Guenthner ST, Hurwitz RM, Buckel LJ, Gray HR. - Cutaneous squamous cell carcinomas consistently show histologic evidence of in situ changes : a clinicopathologic correlation. J Am Acad Dermatol, 1999, 41, 443-448.
Carlson JA, Scott D, Warton J, Sell S. - Incidental histopathologic pattern : possible evidence of «field cancerization » surrounding skin tumors. Am J Dermatopathol, 2001, 23, 494-497.
Henry F, Piérard-Franchimont, Piérard GE. - Photoprotection cutanée. Rev Méd Liège, 2005, 60, S103-S108.
Van der Pols JC, Williams GM, Pandeya N, et al. - Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomarkers Prev, 2006, 15, 2546-2548.
Piérard-Franchimont C, Nikkels AF, Henry F, et al.- L'imiquimod : sus aux kératoses actiniques et à la cancérogenèse en champ. Dermatol Actual, 2007, 102, 8-10.
Piérard-Franchimont C, Henry F, Bourguignon R, Piérard GE. - Décimer les carcinomes basocellulaires peu agressifs et les kératoses actiniques par l'imiquimod. Dermatol Actual, 2008, 106, 24-27.
Quatresooz P, Piérard GE. - Imiquimod-responsive basal cell carcinomas and factor XIIIa-enriched dendrocytes. Clin Epx Dermatol, 2003, 28, S27-S29.
Krawtchenko N, Roewert-Huber J, Ulrich M, et al. - A randomized study of topical 5% imiquimod vs topical 5-fluorouracil vs cryosurgery in immunocompetent patients with actinic keratoses : a comparison of clinical and histological outcomes including 1-year follow-up. Br J Dermatol, 2007, 157, 34-40. (Pubitemid 350179628)
Sachse MM, Zimmermann J, Bahmer FA. - Efficiency of topical imiquimod 5% cream in the management of chronic radiation dermatitis with multiple neoplasias. Eur J Dermatol, 2006, 16, 56-58.
Piérard GE, Piérard-Franchimont C, Paquet P, Quatresooz P. - Emerging therapies for ionizing radiation-associated skin field carcinogenesis. Exp Opin Pharmacother, 2009, 10, 813-821.